Mr. Hugin serves as Chairman and Chief Executive Officer of Celgene Corporation, a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for unmet medical needs in cancer and immune-inflammatory disease.  He joined Celgene in June 1999 and has been a Director of Celgene since December 2001.  Mr. Hugin also serves as a Director of The Medicines Company, Atlantic Health System, Inc. and of Family Promise, a national non-profit network assisting homeless families. He serves as Chair-Elect of The Pharmaceutical Research and Manufacturers of America and is a member of the Board of Trustees of The Darden Foundation, University of Virginia as well as a founding Board member of Choose NJ.  Prior to joining Celgene, Mr. Hugin was a Managing Director with J.P. Morgan & Co. Inc. Mr. Hugin received an AB degree from Princeton University in 1976 and an MBA from the University of Virginia in 1985 and served as a United States Marine Corps infantry officer during the intervening period.  Bob and his wife Kathy have three children and live in Summit, New Jersey.

Read Robert Hugin's Incoming Chairman's Remarks [1] at PhRMA's 2013 Annual Meeting in San Diego. 

Health Care Innovation & US Economy: CNBC Interviews Incoming PhRMA Chairman Hugin [2]. Watch the interview here [2].

Protecting U.S. Medical Innovation: A Call To Action From Celgene's CEO [3]